SCHEMBL22199749

SCHEMBL22199749

CC(=O)NCCCCCCCCCCCCC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 1/20 1.00
MAPK1 P28482 2/20 0.73
KDM4E B2RXH2 1/20 0.73
HIF1A Q16665 1/20 0.73
PRMT1 Q99873 1/20 0.68
PAOX Q6QHF9 3/20 0.59
PLA2G2A P14555 1/20 0.56
TSHR P16473 2/20 0.55
LMNA P02545 1/20 0.55
NFKB1 P19838 1/20 0.55
PMP22 Q01453 1/20 0.55
FOLH1 Q04609 1/20 0.53
PLA2G4A P47712 1/20 0.52
EPHX2 P34913 6/20 0.51
ALDH1A1 P00352 1/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
GPR84 Q9NQS5 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4609043 1.00 ADRA1A (1.00) ADRA1AMAPK1KDM4EHIF1APRMT1
SCHEMBL11712278 1.00 ADRA1A (1.00) ADRA1AMAPK1KDM4EHIF1APRMT1
SCHEMBL27099106 1.00 ADRA1A (1.00) ADRA1AMAPK1KDM4EHIF1APRMT1
SCHEMBL7900131 1.00 ADRA1A (1.00) ADRA1AMAPK1KDM4EHIF1APRMT1
SCHEMBL8098661 1.00 ADRA1A (1.00) ADRA1AMAPK1KDM4EHIF1APRMT1
SCHEMBL19816833 1.00 ADRA1A (1.00) ADRA1AMAPK1KDM4EHIF1APRMT1
SCHEMBL11399083 1.00 ADRA1A (1.00) ADRA1AMAPK1KDM4EHIF1APRMT1
Acexamic Acid SCHEMBL24435 1.00 ADRA1A (1.00) ADRA1AMAPK1KDM4EHIF1APRMT1
SCHEMBL1001209 1.00 ADRA1A (1.00) ADRA1AMAPK1KDM4EHIF1APRMT1
Acexamic Acid SCHEMBL1649364 0.98 ADRA1A (0.96) ADRA1AMAPK1KDM4EHIF1APRMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118829251-A Solar cell, preparation method thereof, photovoltaic module, system and power utilization device 宁德时代新能源科技股份有限公司 2024-10-22 CN disclosed
US-11358988-B2 Immunomodulators BRISTOL-MYERS SQUIBB COMPANY (US) 2022-06-14 US disclosed
US-20200216498-A1 IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2020-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11358988-B2 Immunomodulators CD74, ICOS, HAVCR2 ADRA1A 3692/4885MAPK1 4504/4885KDM4E 3560/4885
US-20200216498-A1 IMMUNOMODULATORS CD74, ICOS, HAVCR2 ADRA1A 3692/4885MAPK1 4504/4885KDM4E 3560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.